drugset / Trial / NCT02124447
Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy
Withdrawn
Medical College of Wisconsin
RandomizedParallel-groupSingle-blindScreening
Summary
This will be a 4-way comparison to prospectively evaluate the efficacy and patient tolerability of four commercially available bowel preparations among patients undergoing colonoscopy for screening and surveillance in a single tertiary academic medical center.
Timeline
- Start
- 2014-06
- Primary completion
- 2014-08
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Morphine | Other / unclassified | — | — |
| Comparator | PEG+Asc | Unknown | 2000 ml | — |
| Comparator | Prepopik | Unknown | — | — |
| Comparator | polyethylene glycol | Other / unclassified | 4000 ml | — |
Indications
No indication recorded.